Read the rest of this entry »

Page 1 of 8

Merck and Schering just launched Saphris, a new atypical antipsychotic for Bipolar I disorder and schizophrenia.

You can see the 8-page launch ad to healthcare professionals on AdPharm.

This ad and thousands more can be seen on the AdPharm gallery, the largest keyword searchable online pharmaceutical advertising gallery.

From the gallery

Original image available on AdPharm.net – (2542 x 1800 pixels)

Join the MyBoniva Program and get one month of Boniva free!
I wanted to stop my cone loss. But I did more. I reversed it with Boniva.
MyBoniva is a free program that delivers ideas and support that can help women manage their osteoporosis.

You’ll get:

• One month of Boniva free
• Helpful monthly reminders to take your Boniva delivered by phone, e-mail, or mail
• Updates from Sally Field
• Quarterly newsletters filled with valuable information.

Did you know osteoporosis runs in families? My mother and I both have it. I tried to keep my bones strong, but it wasn’t enough. Now once-monthly Boniva is helping to do more. Studies show, after a year on Boniva, 9 out of 10 women stopped and reversed their bone loss.

Boniva is a prescription medication to treat and prevent postmenopausal osteoporosis.

Ask your doctor if Boniva is right for you.

Enroll today. Call 1-800-240-5977 or visit Bonivafreetrial.com and try Boniva free.

Brand name: Boniva
Generic name/category: ibandronate sodium
Company: Genentech and GlaxoSmithKline
Country/Market: USA, North America
Indication(s)/use: help stop and reverse bone loss in osteoporosis
Target: Consumers (DTC)
Tagline: Help stop and reverse bone loss
Medium: Print ad
Size/duration: One and a half page
Publication/Aired: Prevention – March 2010

To see all of this brand’s ads on AdPharm, click here

Click here to see all Boniva ads on AdPharm

This ad and thousands more can be seen on the AdPharm gallery, the largest keyword searchable online pharmaceutical advertising gallery.

Click on image to view the full-size version as seen on AdPharm.

The latest shape in NSAID therapy
For inflammation and pain after cataract surgery

The ketorolac molecule enhanced, the NSAID advanced.
Optimal outcomes, enhanced patient comfort, and simple BID dosing.

Brand name: Acuvail
Generic name/category: ketorolac tromethamine ophthalmic solution, nonsteroidal anti-inflammatory drugs (NSAIDs) for ophthalmic use
Company: Allergan
Country/Market: USA, North America
Indication(s)/use: pain and inflammation following cataract surgery
Target: Healthcare Professionals (HCP)
Tagline: Your Next NSAID
Medium: print ad
Size/duration: Single-page
Publication/Aired: Ophtalmology Times – January 2010

To see all of this brand’s ads on AdPharm, click here

This ad and thousands more can be seen on the AdPharm gallery, the largest online pharmaceutical advertising gallery.

Page 1
His ADHD symptoms can be disruptive, but there’s a great kid in there.
Now there’s a new way to help him out…
New for the treatment of ADHD

Spread (pages 2 and 3):
Introducing once-daily Intuniv
A new way to reach the kid within
Intuniv demonstrated significant improvement in ADHD symptoms, which can be disruptive.
New for the treatment of ADHD

To see all of the ads from this campaign, click here

Brand name: intuniv
Generic name/category: Guanfacine, Antihypertensive agents, Guanidines, Alpha-adrenergic agonists
Company: Shire
Country/Market: USA, North America
Indication(s)/use: attention-deficit hyperactivity disorder (ADHD)
Target: Healthcare Professionals (HCP)
Tagline: A new way to reach the kid within
Medium: Print ad
Size/duration: Three-page spread
Publication/Aired: Contemporary Pediatrics – November 2009

To see all of this brand’s ads on AdPharm, click here

Click here to see the details and full-size version of this ad on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Brand name: Geodon
Generic name/category: Ziprasidone, Atypical antipsychotic
Company: Pfizer
Country/Market: USA, North America
Indication(s)/use: acute agitation in schizophrenic patients and acute treatment of mania and mixed states associated with bipolar disorder
Target: Healthcare Professionals (HCP)
Tagline: See me for who I can be
Medium: Print ad
Size/duration: single-page
Publication/Aired: October and November 2009

To see all of this brand’s ads on AdPharm, click here

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Click on image for original file provided by AdPharm

“My migraines are so excruciating I just want to take my head off.”

Treximet is superior to the ingredient in Imitrex tablets at relieving migraine pain.

Brand name: Treximet
Generic name/category: sumatriptan and naproxen, triptan, nonsteroidal anti-inflammatory drugs (NSAIDs)
Company: GlaxoSmithKline (GSK)
Country/Market: USA, North America
Indication(s)/use: Migraine
Target: Consumers (DTC)
Tagline: My migraines are so excruciating I just want to take my head off
Medium: Print ad
Size/duration: single-page
Publication/Aired: Woman’s Day – November 2009

To see all of this brand’s ads on AdPharm, click here

Treximet (formerly known as Trexima) is a medication manufactured by GlaxoSmithKline and POZEN Pharmaceutical Development Company for the treatment of migraines.
It combines sumatriptan (as the succinate), a selective 5-hydroxytryptamine1 (5-HT1) receptor subtype agonist and naproxen sodium, a member of the arylacetic acid group of nonsteroidal anti-inflammatory drugs (NSAIDs), to provide better relief than plain sumatriptan 85 mg, (ie: Imitrex) and anti-inflammatory painkiller, naproxen sodium (the active ingredient in Aleve and Naprosyn) 500 mg, alone would do.

More on Wikipedia

As seen on AdPharm,the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.